Cargando…

Propolis - based chitosan varnish: drug delivery, controlled release and antimicrobial activity against oral pathogen bacteria

BACKGROUND: Dental caries is the most prevalent oral disease in several Asian and Latin American countries. It is an infectious disease and different types of bacteria are involved in the process. Synthetic antimicrobials are used against this disease; however, many of these substances cause unwarra...

Descripción completa

Detalles Bibliográficos
Autores principales: Franca, Juçara R, De Luca, Mariana P, Ribeiro, Tatiana G, Castilho, Rachel O, Moreira, Allyson N, Santos, Vagner R, Faraco, André AG
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4295328/
https://www.ncbi.nlm.nih.gov/pubmed/25495921
http://dx.doi.org/10.1186/1472-6882-14-478
_version_ 1782352827437285376
author Franca, Juçara R
De Luca, Mariana P
Ribeiro, Tatiana G
Castilho, Rachel O
Moreira, Allyson N
Santos, Vagner R
Faraco, André AG
author_facet Franca, Juçara R
De Luca, Mariana P
Ribeiro, Tatiana G
Castilho, Rachel O
Moreira, Allyson N
Santos, Vagner R
Faraco, André AG
author_sort Franca, Juçara R
collection PubMed
description BACKGROUND: Dental caries is the most prevalent oral disease in several Asian and Latin American countries. It is an infectious disease and different types of bacteria are involved in the process. Synthetic antimicrobials are used against this disease; however, many of these substances cause unwarranted undesirable effects like vomiting, diarrhea and tooth staining. Propolis, a resinous substance collected by honeybees, has been used to control the oral microbiota. So, the objective of this study was to develop and characterize sustained-release propolis-based chitosan varnish useful on dental cariogenic biofilm prevention, besides the in vitro antimicrobial activity. METHODS: Three formulations of propolis - based chitosan varnish (PCV) containing different concentrations (5%, 10% and 15%) were produced by dissolution of propolis with chitosan on hydro-alcoholic vehicle. Bovine teeth were used for testing adhesion of coatings and to observe the controlled release of propolis associated with varnish. It was characterized by infrared spectroscopy, scanning electron microscopy, casting time, diffusion test in vitro antimicrobial activity and controlled release. Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) were tested for the main microorganisms involved in the cariogenic biofilm through the microdilution test in 96-well plates. RESULTS: The formulations presented a tooth surface adherence and were able to form films very fast on bovine tooth surface. Also, propolis-based chitosan varnishes have shown antimicrobial activity similar to or better than chlorhexidine varnish against all oral pathogen bacteria. All microorganisms were sensitive to propolis varnish and chitosan. MIC and MBC for microorganisms of cariogenic biofilme showed better results than chlorhexidine. Propolis active components were released for more than one week. CONCLUSION: All developed formulations turn them, 5%, 10% and 15% propolis content varnish, into products suitable for clinical application on dental caries prevention field, deserving clinical studies to confirm its in vivo activity.
format Online
Article
Text
id pubmed-4295328
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42953282015-01-16 Propolis - based chitosan varnish: drug delivery, controlled release and antimicrobial activity against oral pathogen bacteria Franca, Juçara R De Luca, Mariana P Ribeiro, Tatiana G Castilho, Rachel O Moreira, Allyson N Santos, Vagner R Faraco, André AG BMC Complement Altern Med Research Article BACKGROUND: Dental caries is the most prevalent oral disease in several Asian and Latin American countries. It is an infectious disease and different types of bacteria are involved in the process. Synthetic antimicrobials are used against this disease; however, many of these substances cause unwarranted undesirable effects like vomiting, diarrhea and tooth staining. Propolis, a resinous substance collected by honeybees, has been used to control the oral microbiota. So, the objective of this study was to develop and characterize sustained-release propolis-based chitosan varnish useful on dental cariogenic biofilm prevention, besides the in vitro antimicrobial activity. METHODS: Three formulations of propolis - based chitosan varnish (PCV) containing different concentrations (5%, 10% and 15%) were produced by dissolution of propolis with chitosan on hydro-alcoholic vehicle. Bovine teeth were used for testing adhesion of coatings and to observe the controlled release of propolis associated with varnish. It was characterized by infrared spectroscopy, scanning electron microscopy, casting time, diffusion test in vitro antimicrobial activity and controlled release. Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) were tested for the main microorganisms involved in the cariogenic biofilm through the microdilution test in 96-well plates. RESULTS: The formulations presented a tooth surface adherence and were able to form films very fast on bovine tooth surface. Also, propolis-based chitosan varnishes have shown antimicrobial activity similar to or better than chlorhexidine varnish against all oral pathogen bacteria. All microorganisms were sensitive to propolis varnish and chitosan. MIC and MBC for microorganisms of cariogenic biofilme showed better results than chlorhexidine. Propolis active components were released for more than one week. CONCLUSION: All developed formulations turn them, 5%, 10% and 15% propolis content varnish, into products suitable for clinical application on dental caries prevention field, deserving clinical studies to confirm its in vivo activity. BioMed Central 2014-12-12 /pmc/articles/PMC4295328/ /pubmed/25495921 http://dx.doi.org/10.1186/1472-6882-14-478 Text en © Franca et al.; licensee BioMed Central. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Franca, Juçara R
De Luca, Mariana P
Ribeiro, Tatiana G
Castilho, Rachel O
Moreira, Allyson N
Santos, Vagner R
Faraco, André AG
Propolis - based chitosan varnish: drug delivery, controlled release and antimicrobial activity against oral pathogen bacteria
title Propolis - based chitosan varnish: drug delivery, controlled release and antimicrobial activity against oral pathogen bacteria
title_full Propolis - based chitosan varnish: drug delivery, controlled release and antimicrobial activity against oral pathogen bacteria
title_fullStr Propolis - based chitosan varnish: drug delivery, controlled release and antimicrobial activity against oral pathogen bacteria
title_full_unstemmed Propolis - based chitosan varnish: drug delivery, controlled release and antimicrobial activity against oral pathogen bacteria
title_short Propolis - based chitosan varnish: drug delivery, controlled release and antimicrobial activity against oral pathogen bacteria
title_sort propolis - based chitosan varnish: drug delivery, controlled release and antimicrobial activity against oral pathogen bacteria
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4295328/
https://www.ncbi.nlm.nih.gov/pubmed/25495921
http://dx.doi.org/10.1186/1472-6882-14-478
work_keys_str_mv AT francajucarar propolisbasedchitosanvarnishdrugdeliverycontrolledreleaseandantimicrobialactivityagainstoralpathogenbacteria
AT delucamarianap propolisbasedchitosanvarnishdrugdeliverycontrolledreleaseandantimicrobialactivityagainstoralpathogenbacteria
AT ribeirotatianag propolisbasedchitosanvarnishdrugdeliverycontrolledreleaseandantimicrobialactivityagainstoralpathogenbacteria
AT castilhorachelo propolisbasedchitosanvarnishdrugdeliverycontrolledreleaseandantimicrobialactivityagainstoralpathogenbacteria
AT moreiraallysonn propolisbasedchitosanvarnishdrugdeliverycontrolledreleaseandantimicrobialactivityagainstoralpathogenbacteria
AT santosvagnerr propolisbasedchitosanvarnishdrugdeliverycontrolledreleaseandantimicrobialactivityagainstoralpathogenbacteria
AT faracoandreag propolisbasedchitosanvarnishdrugdeliverycontrolledreleaseandantimicrobialactivityagainstoralpathogenbacteria